Tag: ALIMTA

February 2, 2017 Off

Eli Lilly keeps Alimta patent in Japan for now, new challenges on the way

Japan IP High Court confirmed validity of Eli Lilly’s Alimta vitamin regimen patents, and has invalidated trials initiated by Sawai regarding Lilly’s vitamin regimen patents for Alimta.

October 9, 2016 Off

New Data on the Combination of Lilly’s ALIMTA and Merck’s KEYTRUDA

By Dino Mustafić

Important clinical study results from one of Eli Lilly and Company’s ongoing immuno-oncology collaborations with Merck (known as MSD outside…